• Hereditary Breast Cancer Gene Mutation Panel, NGS (BreastNext®)
  • Class of Anticonvulsants
  • MUTYH Gene Mutation Analysis (Y165C and G382D) for MUTYH associated polyposis (MAP)
  • Cytochrome P450 2C19 (CYP2C19) Genotyping
  • Phenosense HIV Drug Resistance Replication Capacity
  • HIV1/HIV2 Antibody Screen, 3rd Generation
  • Gastrointestinal Stromal Tumor Gene Mutation Panel, NGS
  • MGMT (O-6-methylguanine-DNA methyltransferase) Methylation Detection
  • Tacrolimus
  • Vanillylmandelic Acid (VMA) and Homovanillic Acid (HVA), Random, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Primary Hyperoxaluria Gene Mutation Panel
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Primary Hyperoxaluria Gene Mutation Panel
Medical Test

Turnaround Time
Access to Primary Hyperoxaluria Gene Mutation Panel is restricted.